We who use Boots medicines should expect some consideration
I wonder whether Boots The Chemists is truly a health care company? Despite being normotensive with a cholesterol level of 4.3mmol/L, thanks to amlodipine and simvastatin, I have been refused travel insurance by Boots.
My level of cardiovascular risk is well below that recognised in most guidelines of 20 per cent over the next 10 years, but I have been unable to obtain an explanation from the company or its actuaries of the level of risk they are willing to accept. Perhaps they are only willing to accept premiums from those unlikely to make a claim.
I recognise that it is not a charity, but if we are to benefit from the medicines dispensed by Boots we should expect some consideration other than blank refusal.
Insurance companies need to be informed of the beneficial outcomes of modern medicines.
East Molesey, Surrey
KEVIN JOHNSON, general manager, Boots Insurance Services, responds:
Boots’s travel insurance has been designed to ensure that all our customers have full medical cover while they are abroad, including cover for pre-existing conditions.
We have worked hard to include as many pre-existing conditions as possible within our standard policy, so for example people with well controlled asthma can get full cover for their condition at the standard price.
Although we are unable to comment specifically on an individual basis, in line with other insurers, applications are assessed and based on a customer’s medical condition and are not based on cardiovascular risk prediction charts. Where there is a combination of certain medical conditions we are unable to provide cover on our standard policy.
Where we are unable to offer our standard product, we refer our customers to a different policy where the condition will be covered for an additional charge.
Citation: Electronicjuice URI: 10003752
Recommended from Pharmaceutical Press
Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£138.50
Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£262.50
Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.£22.00
A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.£33.00
Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.£40.00